Skip to main content
Avivagen Inc. logo

Avivagen Inc. — Investor Relations & Filings

Ticker · VIV ISIN · CA05382F2026 TSXV Manufacturing
Open in API
Filings indexed 552 across all filing types
Latest filing 2021-02-22 Regulatory Filings
Country CA Canada
Listing TSXV VIV

About Avivagen Inc.

http://www.avivagen.com

Avivagen Inc. was a life sciences corporation focused on developing and commercializing natural health products for livestock, companion animals, and humans. The company specialized in feed additives designed to support immune function and promote growth in animals, emphasizing science-based validation through clinical trials. On April 23, 2024, Avivagen Inc. filed a voluntary assignment in bankruptcy, and a trustee was appointed to manage the proceedings.

Recent filings

Filing Released Lang Actions
Documents affecting rights of securityholders.pdf
Regulatory Filings
2021-02-22 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the publication of a scientific paper reporting the results of a livestock dairy trial conducted by Avivagen. It discusses the trial's findings, the journal where the paper was accepted, and the implications for the company's product sales. There are no financial statements, regulatory filings, or detailed financial data presented. The document is primarily an announcement of the publication of a research report, not the report itself or a financial or regulatory filing. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement and does not fit other specific categories.
2021-02-18 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings
2021-02-16 English
News release - English.pdf
Regulatory Filings
2021-02-16 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the filing of a final short form prospectus for a $7.5 million bought deal unit offering by Avivagen Inc. It details the offering terms, use of proceeds, underwriter fees, and regulatory approvals required. There are no financial statements or substantive financial data presented, only an announcement of a financing event and filing. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or regulatory filing. The document length is sufficient and contains detailed information about the financing, confirming it is not a brief report publication announcement or a regulatory filing certification. Therefore, the appropriate classification is CAP with high confidence.
2021-02-10 English
Decision Document (Final).PDF
Regulatory Filings
2021-02-09 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.